ARQT · Arcutis Biotherapeutics, Inc. · Documents
$31.87
-0.95 (-2.89%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$3.99B
Shares
125.69M
Volume · Oct 21
1.69M
Avg daily vol (3M)
2.4M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| Investor Event Transcript | — | 2026-09-16 | 2026-09-30 | |
| 8-K | — | 2026-08-05 | 2026-07-31 | |
| 10-Q | — | 2026-08-05 | 2026-06-30 | |
| 8-K | — | 2026-07-16 | 2026-07-15 | |
| 8-K | — | 2026-06-09 | 2026-06-05 | |
| Investor Event Transcript | — | 2026-06-09 | 2026-06-30 | |
| 10-Q | — | 2026-05-06 | 2026-03-31 | |
| 8-K | — | 2026-05-06 | — | |
| DEFA14A | — | 2026-04-21 | — | |
| ARS | — | 2026-04-21 | — | |
| DEF 14A | — | 2026-04-21 | — | |
| Investor Event Transcript | — | 2026-04-14 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-03-02 | 2026-03-31 | |
| S-3ASR | — | 2026-02-25 | — | |
| 10-K | — | 2026-02-25 | 2025-12-31 | |
| 8-K | — | 2026-02-25 | — | |
| 8-K | — | 2025-12-08 | 2025-12-03 | |
| 10-Q | — | 2025-10-28 | 2025-09-30 | |
| 8-K | — | 2025-10-28 | — | |
| 8-K | — | 2025-08-06 | — | |
| 10-Q | — | 2025-08-06 | 2025-06-30 | |
| 8-K | — | 2025-06-17 | 2025-06-12 | |
| 10-Q | — | 2025-05-06 | 2025-03-31 | |
| 8-K | — | 2025-05-06 | — | |
| ARS | — | 2025-04-29 | 2025-04-28 | |
| DEFA14A | — | 2025-04-29 | — | |
| DEF 14A | — | 2025-04-29 | 2025-06-12 | |
| 8-K | — | 2025-04-10 | — | |
| 8-K | — | 2025-02-25 | — | |
| 10-K | — | 2025-02-25 | 2024-12-31 | |
| 8-K | — | 2025-01-13 | 2025-01-12 | |
| 8-K | — | 2024-11-06 | — | |
| 10-Q | — | 2024-11-06 | 2024-09-30 | |
| 8-K | — | 2024-08-14 | — | |
| 10-Q | — | 2024-08-14 | 2024-06-30 | |
| 10-Q/A | — | 2024-07-24 | 2024-03-31 | |
| 8-K | — | 2024-06-18 | 2024-06-14 | |
| 8-K | — | 2024-05-14 | — | |
| 10-Q | — | 2024-05-14 | 2024-03-31 | |
| ARS | — | 2024-04-26 | — | |
| DEF 14A | — | 2024-04-26 | — | |
| DEFA14A | — | 2024-04-26 | — | |
| 8-K | — | 2024-04-10 | — | |
| 8-K | — | 2024-03-04 | 2024-02-28 | |
| 8-K | — | 2024-02-28 | 2024-02-27 | |
| 10-K | — | 2024-02-27 | 2023-12-31 | |
| 8-K | — | 2024-02-27 | — | |
| SC TO-I/A | — | 2024-02-15 | — | |
| 8-K | — | 2024-02-15 | 2024-02-12 | |
| S-3 | — | 2024-01-31 | — |
Showing 1–50 of 134 filings
Key facts
CIK
1787306
CUSIP
03969K108
13F (30d)
33 filings
33 filers
Visit website
Investor relations